Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Peritonitis - Overview
Peritonitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Peritonitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peritonitis - Companies Involved in Therapeutics Development
Arrevus Inc
AstraZeneca Plc
Ayuvis Research Inc
Cantargia AB
Hun Sanqing Pharmaceutical Co Ltd
Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd
Nosopharm SAS
Oncodesign SA
Reponex Pharmaceuticals AS
Syct Pharma AB
Peritonitis - Drug Profiles
(avibactam + aztreom) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AP-1189 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARV-1502 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aspoxicillin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AVR-25 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAN-10 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ceforanide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
molgramostim - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NOSO-502 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ODS-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit NLRP3 for Inflammatory Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peritonitis - Dormant Projects
Peritonitis - Product Development Milestones
Featured News & Press Releases
Apr 26, 2021: Cantargia presents new preclinical data on antibody CAN10 at IMMMUNOLOGY2021
Jun 19, 2016: Reponex Pharmaceuticals: The Danish Medicines Agency has approved the clinical trial protocol for the peritonitis project
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Peritonitis, 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Peritonitis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Peritonitis - Pipeline by Arrevus Inc, 2021
Peritonitis - Pipeline by AstraZeneca Plc, 2021
Peritonitis - Pipeline by Ayuvis Research Inc, 2021
Peritonitis - Pipeline by Cantargia AB, 2021
Peritonitis - Pipeline by Hunan Sanqing Pharmaceutical Co Ltd, 2021
Peritonitis - Pipeline by Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd, 2021
Peritonitis - Pipeline by Nosopharm SAS, 2021
Peritonitis - Pipeline by Oncodesign SA, 2021
Peritonitis - Pipeline by Reponex Pharmaceuticals AS, 2021
Peritonitis - Pipeline by SynAct Pharma AB, 2021
Peritonitis - Dormant Projects, 2021